GlucoTrack (GCTK) Competitors $5.77 +0.05 (+0.87%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$5.72 -0.05 (-0.87%) As of 08/15/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GCTK vs. QTI, LYRA, TNON, INBS, LUCY, ICU, HSCS, CODX, SINT, and SSKNShould you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include QT Imaging (QTI), Lyra Therapeutics (LYRA), Tenon Medical (TNON), Intelligent Bio Solutions (INBS), Innovative Eyewear (LUCY), SeaStar Medical (ICU), HeartSciences (HSCS), Co-Diagnostics (CODX), Sintx Technologies (SINT), and Strata Skin Sciences (SSKN). These companies are all part of the "medical equipment" industry. GlucoTrack vs. Its Competitors QT Imaging Lyra Therapeutics Tenon Medical Intelligent Bio Solutions Innovative Eyewear SeaStar Medical HeartSciences Co-Diagnostics Sintx Technologies Strata Skin Sciences QT Imaging (NASDAQ:QTI) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings. Which has more risk and volatility, QTI or GCTK? QT Imaging has a beta of -0.2, suggesting that its stock price is 120% less volatile than the S&P 500. Comparatively, GlucoTrack has a beta of -0.19, suggesting that its stock price is 119% less volatile than the S&P 500. Is QTI or GCTK more profitable? Company Net Margins Return on Equity Return on Assets QT ImagingN/A N/A -65.94% GlucoTrack N/A N/A -428.72% Do institutionals & insiders have more ownership in QTI or GCTK? 24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 12.9% of GlucoTrack shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable valuation and earnings, QTI or GCTK? QT Imaging has higher revenue and earnings than GlucoTrack. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQT Imaging$4.00M13.58-$4.03MN/AN/AGlucoTrackN/AN/A-$22.60M-$56.60-0.10 Does the media refer more to QTI or GCTK? In the previous week, GlucoTrack had 5 more articles in the media than QT Imaging. MarketBeat recorded 5 mentions for GlucoTrack and 0 mentions for QT Imaging. GlucoTrack's average media sentiment score of 0.65 beat QT Imaging's score of 0.00 indicating that GlucoTrack is being referred to more favorably in the news media. Company Overall Sentiment QT Imaging Neutral GlucoTrack Positive SummaryQT Imaging beats GlucoTrack on 5 of the 8 factors compared between the two stocks. Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GCTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GCTK vs. The Competition Export to ExcelMetricGlucoTrackMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.73M$10.61B$5.67B$9.82BDividend YieldN/A1.97%3.79%4.07%P/E Ratio-0.1019.7130.5825.12Price / SalesN/A31.56460.38114.01Price / CashN/A24.3737.4059.05Price / Book-0.013.399.096.18Net Income-$22.60M$209.94M$3.25B$264.89M7 Day Performance-0.86%13.40%7.42%4.22%1 Month Performance8.05%10.49%5.50%2.02%1 Year Performance-99.77%-10.07%30.67%24.22% GlucoTrack Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GCTKGlucoTrack0.195 of 5 stars$5.77+0.9%N/A-99.8%$2.73MN/A-0.105News CoverageEarnings ReportQTIQT ImagingN/A$1.90+2.7%N/A+321.9%$10.72M$4.00M0.00N/AGap DownLYRALyra Therapeutics2.9944 of 5 stars$6.75+1.2%$100.00+1,381.5%-51.4%$10.66M$1.53M-0.1150News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap DownTNONTenon Medical2.0736 of 5 stars$1.47+6.5%$4.67+217.5%+207.5%$10.47M$3.28M-0.058News CoverageEarnings ReportShort Interest ↑INBSIntelligent Bio Solutions0.7872 of 5 stars$1.47+2.1%N/A+36.7%$9.95M$3.11M0.0010News CoverageAnalyst UpgradeLUCYInnovative Eyewear0.66 of 5 stars$1.97-2.0%N/A-48.5%$9.19M$1.64M-0.499News CoverageEarnings ReportUpcoming EarningsShort Interest ↓ICUSeaStar Medical0.3317 of 5 stars$0.73-6.2%N/A-87.0%$8.72M$140K-0.212Earnings ReportShort Interest ↑Gap DownHSCSHeartSciences3.369 of 5 stars$3.39-9.1%$13.00+283.5%+3.0%$8.49MN/A-0.3610News CoveragePositive NewsShort Interest ↓CODXCo-Diagnostics4.4752 of 5 stars$0.25+0.5%$5.50+2,067.9%-76.3%$8.48M$3.91M-0.22100News CoverageEarnings ReportAnalyst ForecastShort Interest ↓SINTSintx Technologies2.8198 of 5 stars$2.99+3.5%$28.00+836.5%-28.1%$7.96M$2.89M-0.0640News CoverageEarnings ReportShort Interest ↓SSKNStrata Skin Sciences2.3666 of 5 stars$1.81-4.7%$6.00+231.5%-27.8%$7.92M$33.56M-0.80120News CoverageEarnings ReportShort Interest ↑ Related Companies and Tools Related Companies QTI Alternatives LYRA Alternatives TNON Alternatives INBS Alternatives LUCY Alternatives ICU Alternatives HSCS Alternatives CODX Alternatives SINT Alternatives SSKN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GCTK) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access